首页 >
法规速递
-
关于公开征求《人纤维蛋白原临床试验技术指导原则（修订版征求意见稿）》意见的通知-2023/9/4
2023-09-05查看详情 > -
国家药监局关于废止YY/T 0771.1-2020 《动物源医疗器械 第1部分：风险管理应用》和YY/T 0771.2-2020 《动物源医疗器械 第2部分：来源、收集与处置的控制》医疗器械行业标准的公告（2024年第157号）-2025/1/6
2025-01-07查看详情 > -
Page: Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline-2025/2/6
2025-02-10查看详情 > -
Document: Frequently asked questions (FAQs): How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10-2025/3/14
2025-03-17查看详情 > -
Page: Fees payable to the European Medicines Agency: Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices-2025/4/15
2025-04-16查看详情 > -
国家药监局综合司再次公开征求《关于加强药品受托生产监督管理工作的公告（征求意见稿）》意见 -2025/5/30
2025-05-30查看详情 > -
Document: Network Data Steering Group workplan 2025-2028-2025/7/2
2025-07-03查看详情 > -
Document: CHMP-CAT - D80-210 Overview to final EPAR - Rev 07.25 Revamp-2025/8/5
2025-08-06查看详情 > -
Page: Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)-2025/9/24
2025-09-25查看详情 > -
Document: List of medicines currently in PRIME scheme-2025/10/31
2025-11-03查看详情 >
